Emerging Frontiers in Drug Delivery

被引:845
作者
Tibbitt, Mark W. [1 ,2 ]
Dahlman, James E. [3 ,4 ]
Langer, Robert [1 ,2 ,5 ]
机构
[1] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA
[2] MIT, Dept Chem Engn, Cambridge, MA 02142 USA
[3] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[4] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA
[5] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA
关键词
MODIFIED MESSENGER-RNA; TUMOR-TARGETED SALMONELLA; PLACEBO-CONTROLLED TRIAL; IRRITABLE-BOWEL-SYNDROME; LIPID-LIKE MATERIALS; CELL-BASED THERAPY; IN-VIVO DELIVERY; SIRNA DELIVERY; CONTROLLED-RELEASE; SUSTAINED-RELEASE;
D O I
10.1021/jacs.5b09974
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Medicine relies on the use of pharmacologically active agents (drugs) to manage and treat disease. However, drugs are not inherently effective; the benefit of a drug is directly related to the manner by which it is administered or delivered. Drug delivery can affect drug pharmacokinetics, absorption, distribution, metabolism, duration of therapeutic effect, excretion, and toxicity. As new therapeutics (e.g., biologics) are being developed, there is an accompanying need for improved chemistries and materials to deliver them to the target site in the body, at a therapeutic concentration, and for the required period of time. In this Perspective, we provide an historical overview of drug delivery and controlled release followed by highlights of four emerging areas in the field of drug delivery: systemic RNA delivery, drug delivery for localized therapy, oral drug delivery systems, and biologic drug delivery systems. In each case, we present the barriers to effective drug delivery as well as chemical and materials advances that are enabling the field to overcome these hurdles for clinical impact.
引用
收藏
页码:704 / 717
页数:14
相关论文
共 264 条
[1]
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics [J].
Akinc, Akin ;
Zumbuehl, Andreas ;
Goldberg, Michael ;
Leshchiner, Elizaveta S. ;
Busini, Valentina ;
Hossain, Naushad ;
Bacallado, Sergio A. ;
Nguyen, David N. ;
Fuller, Jason ;
Alvarez, Rene ;
Borodovsky, Anna ;
Borland, Todd ;
Constien, Rainer ;
de Fougerolles, Antonin ;
Dorkin, J. Robert ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
John, Matthias ;
Koteliansky, Victor ;
Manoharan, Muthiah ;
Nechev, Lubomir ;
Qin, June ;
Racie, Timothy ;
Raitcheva, Denitza ;
Rajeev, Kallanthottathil G. ;
Sah, Dinah W. Y. ;
Soutschek, Juergen ;
Toudjarska, Ivanka ;
Vornlocher, Hans-Peter ;
Zimmermann, Tracy S. ;
Langer, Robert ;
Anderson, Daniel G. .
NATURE BIOTECHNOLOGY, 2008, 26 (05) :561-569
[2]
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms [J].
Akinc, Akin ;
Querbes, William ;
De, Soma ;
Qin, June ;
Frank-Kamenetsky, Maria ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
Rajeev, Kallanthottathil G. ;
Cantley, William L. ;
Dorkin, J. Robert ;
Butler, James S. ;
Qin, LiuLiang ;
Racie, Timothy ;
Sprague, Andrew ;
Fava, Eugenio ;
Zeigerer, Anja ;
Hope, Michael J. ;
Zerial, Marino ;
Sah, Dinah W. Y. ;
Fitzgerald, Kevin ;
Tracy, Mark A. ;
Manoharan, Muthiah ;
Koteliansky, Victor ;
de Fougerolles, Antonin ;
Maier, Martin A. .
MOLECULAR THERAPY, 2010, 18 (07) :1357-1364
[3]
Development of Lipidoid-siRNA Formulations for Systemic Delivery to the Liver [J].
Akinc, Akin ;
Goldberg, Michael ;
Qin, June ;
Dorkin, J. Robert ;
Gamba-Vitalo, Christina ;
Maier, Martin ;
Jayaprakash, K. Narayanannair ;
Jayaraman, Muthusamy ;
Rajeev, Kallanthottathil G. ;
Manoharan, Muthiah ;
Koteliansky, Victor ;
Roehl, Ingo ;
Leshchiner, Elizaveta S. ;
Langer, Robert ;
Anderson, Daniel G. .
MOLECULAR THERAPY, 2009, 17 (05) :872-879
[4]
Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression [J].
Aleku, Manuela ;
Schulz, Petra ;
Keil, Oliver ;
Santel, Ansgar ;
Schaeper, Ute ;
Dieckhoff, Britta ;
Janke, Oliver ;
Endruschat, Jens ;
Durieux, Birgit ;
Roeder, Nadine ;
Loeffler, Kathrin ;
Lange, Christian ;
Fechtner, Melanie ;
Moepert, Kristin ;
Fisch, Gerald ;
Dames, Sibylle ;
Arnold, Wolfgang ;
Jochims, Karin ;
Giese, Klaus ;
Wiedenmann, Bertram ;
Scholz, Arne ;
Kaufmann, Joerg .
CANCER RESEARCH, 2008, 68 (23) :9788-9798
[5]
The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages [J].
Allavena, Paola ;
Sica, Antonio ;
Solinas, Graziella ;
Porta, Chiara ;
Mantovani, Alberto .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) :1-9
[6]
Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[7]
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J].
Alvarez-Erviti, Lydia ;
Seow, Yiqi ;
Yin, HaiFang ;
Betts, Corinne ;
Lakhal, Samira ;
Wood, Matthew J. A. .
NATURE BIOTECHNOLOGY, 2011, 29 (04) :341-U179
[8]
Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients - A pilot uncontrolled study [J].
Annese, V ;
Latiano, A ;
Rossi, L ;
Lombardi, G ;
Dallapiccola, B ;
Serafini, S ;
Damonte, G ;
Andriulli, A ;
Magnani, M .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (06) :1370-1375
[9]
[Anonymous], 2003, Adherence to Long-Term Therapies: Evidence for action
[10]
[Anonymous], 2011, GOODMAN GILMANS PHAR